Albion Financial Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.81K	Hold	3,043	–	–	﹤0.01%	482
2025 Q4	$5.08K	Hold	3,043	–	–	﹤0.01%	465
2025 Q3	$5.14K	Hold	3,043	–	–	﹤0.01%	449
2025 Q2	$2.76K	Hold	3,043	–	–	﹤0.01%	461
2025 Q1	$1.38K	Hold	3,043	–	–	﹤0.01%	510
2024 Q4	$1.53K	Hold	3,043	–	–	﹤0.01%	572
2024 Q3	$2.75K	Hold	3,043	–	–	﹤0.01%	408
2024 Q2	$3.04K	Hold	3,043	–	–	﹤0.01%	403
2024 Q1	$4.5K	Hold	3,043	–	–	﹤0.01%	363
2023 Q4	$3.32K	Hold	3,043	–	–	﹤0.01%	370
2023 Q3	$3.59K	Hold	3,043	–	–	﹤0.01%	346
2023 Q2	$4.29K	Hold	3,043	–	–	﹤0.01%	343
2023 Q1	$4.57K	Hold	3,043	–	–	﹤0.01%	339
2022 Q4	$3.56K	Hold	3,043	–	–	﹤0.01%	354
2022 Q3	$3K	Hold	3,043	–	–	﹤0.01%	374
2022 Q2	$5K	Hold	3,043	–	–	﹤0.01%	356
2022 Q1	$5K	Hold	3,043	–	–	﹤0.01%	413
2021 Q4	$7K	Hold	3,043	–	–	﹤0.01%	429
2021 Q3	$8K	Hold	3,043	–	–	﹤0.01%	392
2021 Q2	$9K	Buy	+3,043	New	+$7.87K	﹤0.01%	381
2020 Q4	$5K	Buy	+3,043	New	+$4.25K	﹤0.01%	383
2015 Q4	–	Sell	-28,603	Closed	-$69K	–	176
2015 Q3	$69K	Hold	28,603	–	–	0.01%	175
2015 Q2	$84K	Hold	28,603	–	–	0.01%	180
2015 Q1	$115K	Hold	28,603	–	–	0.02%	173
2014 Q4	$86K	Hold	28,603	–	–	0.01%	174
2014 Q3	$72K	Hold	28,603	–	–	0.01%	177
2014 Q2	$70K	Hold	28,603	–	–	0.01%	188
2014 Q1	$76K	Hold	28,603	–	–	0.01%	185
2013 Q4	$83K	Hold	28,603	–	–	0.02%	168
2013 Q3	$88K	Hold	28,603	–	–	0.02%	168
2013 Q2	$91K	Buy	+28,603	New	+$91.6K	0.02%	154

Other funds holding LCTX